CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Benjamin Rolland

OPENALEX: A5003391709↗ORCID: 0000-0002-8666-3635↗

Affiliations

Organizations

AstraZeneca (Brazil)authorship · BR Bristol-Myers Squibb (Germany)authorship · DE Centre de Recherche en Neurosciences de Lyonauthorship · FR Centre Hospitalier Le Vinatierauthorship · FR Centre Hospitalier Universitaire de Lilleauthorship · FR Centre National de la Recherche Scientifiqueauthorship · FR Délégation Régionale Auvergne-Rhône-Alpesauthorship · FR Hôpital Edouard Herriotauthorship · FR Hospices Civils de Lyonauthorship · FR Insermauthorship · FR Lundbeck (Denmark)authorship · DK Lyon 1 Universitéauthorship · FR Reckitt Benckiser (United Kingdom)authorship · GB Université de Lilleauthorship · FR Université de Lyonauthorship · FR Université Lille Nord de Franceauthorship · FR

Public evidence

2 connected articles

Association between formal thought disorder and cannabis use: a systematic review and meta-analysis2022 · PubMed Central Open Access Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study.2018 · PubMed Central Open Access

Registered research

Connected studies

Prevalence and Risk Factors for Persistent Tobacco or Alcohol Use Over the First Year of a First Lung or Head and Neck Cancernct01647425

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Benjamin Rolland - Medical Cannabis Research Engine